Chemoradiation-induced superior vena cava syndrome: a case report.
A case of a 54-year-old man who developed superior vena cava syndrome secondary to vascular fibrosis, 30 months after radical chemoradiation for stage III non-small cell lung cancer, is presented. The literature regarding the etiology, diagnosis and treatment of this rare entity is discussed.
Castonguay
Mathieu
M
Department of Pathology, The University of Western Ontario, London, Canada.
Rodrigues
George
G
Vincent
Mark
M
Malthaner
Richard A
RA
Guo
Lin-Ruo
LR
D000230:Adenocarcinoma / Q000188:drug therapy / Q000453:epidemiology / Q000532:radiotherapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D030161:Avian Proteins; D001932:Brain Neoplasms / Q000532:radiotherapy / Q000556:secondary; D015815:Cell Adhesion Molecules; D003131:Combined Modality Therapy; D015897:Comorbidity; D001026:Coronary Artery Bypass; D019583:Dose Fractionation, Radiation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins; D009203:Myocardial Infarction / Q000453:epidemiology / Q000601:surgery; D011859:Radiography; D011878:Radiotherapy / Q000009:adverse effects; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000209:etiology* / Q000601:surgery; D013997:Time Factors
D030161:Avian Proteins; C498788:Bves protein, Gallus gallus; D015815:Cell Adhesion Molecules; D009124:Muscle Proteins